Oct 26 (Reuters) -
Kainos Laboratories Inc
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2016 Mar 31, 2016
LATEST PREVIOUS
FORECAST FORECAST
Sales 5.30 5.80
Operating 410 mln 428 mln
Recurring 413 mln 437 mln
Net 280 mln 288 mln
EPS 65.57 yen 64.71 yen
NOTE - Kainos Laboratories Inc is a manufacturer of clinical reagents for biochemical and immune serum studies.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T
((Tokyo Headline News Desk +813 6441 1812))